Zimmer Biomet stock slips as shares close at USD 94.32

Zimmer Biomet Holdings, Inc. (ISIN US98956P1021) closed at USD 94.32 on the New York Stock Exchange on September 22, 2026, down 1.1 percent from the prior session. The price was USD 12.56 below the 52-week high of USD 106.88 and USD 15.20 above the 52-week low of USD 79.12.

Trading range sets the context

The session ranged from USD 93.71 to USD 96.17, while trading volume reached 3,945,673 shares on September 22, 2026. The comparison with the yearly range places the closing price 11.75 percent below the high and 19.22 percent above the low, calculated from the reported levels.

The dated market figures point to a stock trading closer to its annual high than its annual low, although the 1.1 percent daily decline shows that the latest session ended below the previous close. The market reaction is therefore measurable without attributing it to an unsupported company-specific event.

Revenue reached USD 8.23 billion

Historical fiscal-year context remains constructive: Zimmer Biomet reported revenue of USD 8.23 billion for fiscal year 2025, up 7.2 percent from fiscal year 2024 on a reported basis and up 3.9 percent on an organic constant-currency basis, according to The Brand Hopper on September 23, 2026.

The two growth measures provide a useful comparison: reported revenue growth exceeded organic constant-currency growth by 3.3 percentage points in fiscal year 2025. That gap indicates that reported expansion included a currency contribution in addition to underlying business growth, while the latest market close supplies the near-term valuation context.

Stock remains below yearly high

Zimmer Biomet stock ended September 22, 2026, at USD 94.32 on the New York Stock Exchange. The company therefore remains USD 12.56, or 11.75 percent, below the 52-week high of USD 106.88, with the reference price and range taken from the same dated market snapshot.

More news and analyses on Zimmer Biomet stock